KLOW

KLOW is a research combination product containing four synergistic peptides formulated together: GHK-Cu (copper tripeptide, 50 mg), BPC-157 (Body Protection Compound-157, 10 mg), TB-500 (Thymosin Beta-4 fragment, 10 mg), and KPV (α-MSH tripeptide, 10 mg). Each component targets complementary pathways involved in tissue repair, inflammation resolution, and cytoprotection.

Component Profiles:

• GHK-Cu — copper-binding tripeptide; studied for wound healing, angiogenesis, and extracellular matrix remodeling
• BPC-157 — pentadecapeptide; studied for gastrointestinal and musculoskeletal tissue repair
• TB-500 — actin-binding fragment of Thymosin β₄; studied for cell migration, angiogenesis, and inflammation
• KPV — C-terminal tripeptide of α-MSH; studied for anti-inflammatory and gut epithelial protection

Research Applications:

• Multi-pathway tissue regeneration studies
• Inflammatory response modulation research
• Wound healing and angiogenesis models

Product Specifications:
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: −20 °C, protected from light

For research use only. Not for human consumption. Not for veterinary use. No medical or therapeutic claims are made. These statements have not been evaluated by the FDA.